Vanguard Global Advisers
RVPH

Vanguard Global Advisers’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Vanguard Global Advisers’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,115
Closed -$2.27K – 3717
2026
Q1 		$2.27K Buy
+3,115
New +$14.2K ﹤0.01% 3612

Other funds holding RVPH

ECM
EMC Capital Management Houston, Texas $253M AUM
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
PUI
Purpose Unlimited Inc Toronto $2.62B AUM
MGI
Miller Global Investments Dallas, Texas $121M AUM
MWM
Mosley Wealth Management Anaheim, California $314M AUM

Vanguard Global Advisers's RVPH Position: Q2 2026 in Review

Vanguard Global Advisers sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 3,115 shares — an estimated $2.27K sold.

Vanguard Global Advisers first reported a position in RVPH in Q1 2026 and held it in 1 quarter. The position peaked at $2.27K in Q1 2026. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

  • Vanguard Global Advisers reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
  • Vanguard Global Advisers sold 3,115 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $2.27K.
  • Vanguard Global Advisers first reported a position in REVIVA PHARMA HLDGS INC in Q1 2026 and held it in 1 quarter.
  • Vanguard Global Advisers's REVIVA PHARMA HLDGS INC position peaked at $2.27K in Q1 2026.
  • 5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.